AMD — Advanced Micro Devices, Inc.

As of 2026-09-13 the tape and the sell-side agree. Q2 2026 (reported Aug 4, 2026) delivered record revenue of $11.54B, +50.1% YoY, EPS beat (~$1.66 vs ~$1.61 consensus) and Data Center revenue doubled to $6.7B. The late-August Anthropic partnership - up to 2 gigawatts of Instinct GPUs on AMD's Helios rack-scale platform - plus management's raised AI accelerator TAM of roughly $3T by 2030 (up from ~$2T) reinforced AMD as the credible merchant-silicon alternative to Nvidia. Raymond James upgraded to Strong Buy with a $641 target on Aug 25; the ratings mix is 1 strong buy / 49 buy / 20 hold / 0 sell, with a $598.24 consensus target and $654.63 average of recent targets. Price confirms the mood: +8.07% in the week and +6.87% in the month through 2026-09-13, RSI at 57.96. The one blemish is that shares dipped post-earnings on in-line gross-margin guidance and sit 11-17% below the June peak - bullish, but not euphoric.

Revenue has run from $5.80B (Q3 2023) to $11.54B (Q2 2026) and the growth rate is accelerating, not fading: YoY was +17.6% (Q3 2024), +24.2% (Q4 2024), +31.7% (Q2 2025), +35.6% (Q3 2025), +34.1% (Q4 2025), +37.9% (Q1 2026) and +50.1% (Q2 2026). Gross margin has structurally stepped from 46-47% across FY2023 to 50-51% through FY2024/early FY2025 and 52.8-54.3% over the last three quarters; the ugly 39.8% print in Q2 2025 is a one-off (an export-control charge that pushed operating income to -$134M on $7.69B of revenue), not a trend break. Operating margin tells the same story: 3.9-11.4% through 2023-2024 versus 13.7%, 17.1%, 14.4% and 17.2% over the last four quarters. R&D is up 68% since Q3 2023 against 99% revenue growth, so the margin expansion is operating leverage, not just pricing. Diluted EPS went from $0.18 (Q3 2023) to $1.38 (Q2 2026). Cash backs the earnings: TTM free cash flow of $8.40B is roughly 3x the $2.75B of the prior four quarters and the accruals ratio is -0.08% (cash slightly ahead of reported net income). Caveats: Q2 2026 net income of $2.297B exceeded operating income of $1.990B, so non-operating/tax items flattered GAAP EPS, and capex jumped to $808M from $222M in Q4 2025 as capacity ramps. Net: an inflection, not a blip.

Expensive, and not only in absolute terms. As of 2026-09-13: 131.0x trailing P/E vs a 122.96x five-year average; 20.4x trailing sales vs an 8.7x five-year average; 12.5x book; 79.6x EV/EBITDA; roughly 1.0% FCF yield on an $841.6B market cap. The bull case rests on forward math - next-FY consensus EPS of $7.619 implies a ~67.7x forward P/E and the quoted PEG of 1.058 - but that PEG is arithmetic flattery, since the denominator is a one-year earnings spike off a charge-depressed base rather than a durable growth rate. Even if AMD hits the $50.87B next-FY revenue consensus, it still trades around 16.5x forward EV/sales. Verdict: expensive relative to its own history and to its current 15.7% operating margin / 5.4% ROIC, though not irrational if the data-center ramp compounds for years.

The market is paying now for growth that has partly arrived and partly not. Half the thesis is in the numbers already (50.1% revenue growth, Data Center doubling to $6.7B, TTM FCF tripling); the other half is still a promise - MI450 volume production, Helios rack-scale execution, and the multi-gigawatt Meta/Anthropic commitments converting into revenue in 2027+, against a TAM management now pegs at ~$3T by 2030. At ~67.7x forward earnings, that promise is heavily discounted. Practically: earnings beats alone won't move the stock much (Q2 beat, shares still dipped on gross-margin guidance). What re-rates or de-rates the multiple is gross-margin trajectory and firm, dated revenue commitments from the gigawatt-scale deals. If Q3 (Nov 3, 2026) shows revenue above the ~$12-13B sequential run-rate implied by FY consensus with GM pushing toward the mid-to-high 50s, the multiple holds; if revenue beats on lower-margin rack-scale mix, expect multiple compression even as EPS rises. At this multiple, price is a function of the multiple, not the estimate.

As of 2026-09-13, RSI(14) stood at 57.96 - firm but not overbought - with price 7.07% above the 20-day SMA (~$482), 3.94% above the 50-day (~$497) and 48.78% above the 200-day (~$347). Returns through that date: +2.49% on the day, +8.07% over one week, +6.87% over one month, +0.89% over three months, +166.89% over six months, against a 52-week range of $149.85-$584.73. The key read is that three-month flat patch inside a six-month melt-up: AMD consolidated sideways after the late-June peak of $584.73 and has just broken back up on strengthening RSI, so momentum is intact and there is room before overbought. But the 200-day sits 49% below spot, so there is no nearby structural support and the immediate test is the $584.73 high. Entry implication: chasing here is high-beta work; the cleaner entries were the flat three-month base just exited, or a pullback toward the 50-day near $497.

• Hyperscaler AI capex cycle: Microsoft, Meta, Anthropic and OpenAI data-center builds are the single biggest swing factor for AMD's Data Center line; any ROI-driven capex digestion would hit AMD first and hardest.
• US export controls on high-performance chips to China: already caused a real gross-margin hit and inventory charge in Q2 2025, and remains a recurring, hard-to-timing risk to both revenue and reported margins.
• Rates and duration risk: with a 2.476 beta and a 131x trailing P/E, AMD is among the most rate-sensitive large caps - its value is back-end loaded, so rising yields compress the multiple mechanically.
• Competitive intensity: Nvidia's entrenched share in AI accelerators and its push into custom PC processors, plus Intel's CPU roadmap, frame AMD as the challenger rather than the incumbent in its most valuable market.
• Supply chain: advanced packaging (CoWoS), HBM availability and TSMC foundry allocation gate the MI450/Helios ramp - visible in the capex step-up to $808M in Q2 2026 from $222M in Q4 2025.

• Q3 2026 earnings on Nov 3, 2026 - the first clean read on Helios/MI450 supply execution and forward gross-margin trajectory, the two things that drove the post-Q2 selloff.
• Conversion of the Anthropic (up to 2 GW) and Meta multi-gigawatt commitments into firm, dated revenue, plus MI450 production velocity through the back half of 2026.
• Continued server CPU share gains against Intel, the explicit rationale behind Raymond James' Aug 25 upgrade to Strong Buy and $641 price target.
• Further upward revisions to management's AI accelerator TAM (~$3T by 2030) and any additional large-scale AI infrastructure wins that validate the Helios rack-scale platform.
• Sell-side target drift: consensus sits at $598.24 with recent targets averaging $654.63 and a Street high of $1,250 - upgrades and target raises remain a mechanical tailwind.

• Valuation risk is the dominant one: 20.4x TTM sales versus an 8.7x five-year average and 79.6x EV/EBITDA means a 20% multiple compression erases roughly $165B of market cap even if earnings fully deliver.
• Gross-margin execution and mix: Q2 2026 already sold off on in-line GM guidance, and heavier rack-scale/Helios system mix (lower margin than stand-alone GPUs) could structurally cap gross margin well below the 60% bulls expect.
• Nvidia's entrenched dominance and its entry into custom PC processors - AMD is the challenger in AI accelerators, and share gains are not guaranteed at any price.
• Geopolitical/export-control risk: the 2025 MI308 episode shows how quickly a licensing change converts into charges and forgone revenue; recurrence would hit both the P&L and the multiple.
• Cyclicality the trailing numbers cannot flag: AI capex and semis are cyclical, and the deterministic value score (built entirely on trailing YoY growth, margins and ROIC) looks best precisely when the cycle is strongest - it has no mechanism to warn of a demand air pocket.
• Customer concentration: a handful of hyperscalers and AI labs drive the incremental growth; one delayed or rescoped deployment materially moves the outlook.
• Earnings quality nuance: Q2 2026 net income of $2.297B topped operating income of $1.990B on non-operating/tax items, so GAAP EPS growth is flattered relative to core operating momentum.

AMD is a genuinely improving business - accelerating 50.1% revenue growth, gross margin up from ~47% to ~54%, operating margin from ~4% to ~17%, net cash with 0.064 debt/equity and a 2.61 current ratio - and it is the only credible merchant-silicon challenger to Nvidia in AI infrastructure. The problem is entirely price: at $516.13 you pay 20.4x trailing sales and ~67.7x next-year earnings for that, and my own fair-value work lands near $429. The mandatory lean reads Cautiously Bullish because the fundamental band is good while the valuation overlay is rich, and I agree directionally - but the honest read is that the shares are running ahead of what the current numbers support. Own it as an AI-infrastructure growth position, not for valuation support; scale in on weakness toward the low $400s or a retest of the 50-day rather than chasing the current re-acceleration. This is analysis, not personalized advice.

Revenue growth has run from $5.80B (Q3 2023) to $11.54B (Q2 2026) and the growth rate is accelerating, not fading: YoY was +17.6% (Q3 2024), +24.2% (Q4 2024), +31.7% (Q2 2025), +35.6% (Q3 2025), +34.1% (Q4 2025), +37.9% (Q1 2026) and +50.1% (Q2 2026). Gross margin has structurally stepped from 46-47% across FY2023 to 50-51% through FY2024/early FY2025 and 52.8-54.3% over the last three quarters; the ugly 39.8% print in Q2 2025 is a one-off (an export-control charge that pushed operating income to -$134M on $7.69B of revenue), not a trend break. Operating margin tells the same story: 3.9-11.4% through 2023-2024 versus 13.7%, 17.1%, 14.4% and 17.2% over the last four quarters. R&D is up 68% since Q3 2023 against 99% revenue growth, so the margin expansion is operating leverage, not just pricing. Diluted EPS went from $0.18 (Q3 2023) to $1.38 (Q2 2026). Cash backs the earnings: TTM free cash flow of $8.40B is roughly 3x the $2.75B of the prior four quarters and the accruals ratio is -0.08% (cash slightly ahead of reported net income). Caveats: Q2 2026 net income of $2.297B exceeded operating income of $1.990B, so non-operating/tax items flattered GAAP EPS, and capex jumped to $808M from $222M in Q4 2025 as capacity ramps. Net: an inflection, not a blip.